Pulmonary hypertension, hyperthyroidism, and fenfluramine: a case report and review.
We report a case of pulmonary hypertension presenting with sudden cardiac arrest, hyperthyroidism and fenfluramine usage. This fatal case of pulmonary hypertension and valvular heart disease is associated with the use of an anorectic drug that had been withdrawn from the market more than eight years ago. Clinicians should alert to the side effects of appetite suppressant and slimming agents. The association between pulmonary hypertension in relation to hyperthyroidism and fenfluramine usage is reviewed.
Leung
Ying Ying
YY
Department of Medicine and Geriatrics, Tai Po Hospital, Hong Kong SAR.
Tang
Kam Shing
KS
Tsang
Chiu Chi
CC
Chan
Chi Kin
CK
Wong
Kwan Keung
KK
Yu
Alex Wai-yin
AW
D017809:Fatal Outcome; D005260:Female; D005277:Fenfluramine / Q000009:adverse effects*; D006323:Heart Arrest / Q000150:complications / Q000175:diagnosis; D006801:Humans; D006976:Hypertension, Pulmonary / Q000139:chemically induced* / Q000150:complications / Q000175:diagnosis; D006980:Hyperthyroidism / Q000139:chemically induced* / Q000150:complications / Q000175:diagnosis; D008875:Middle Aged
D005277:Fenfluramine